It was also shown that a methylation panel of three genes, Syndecan 2 (SDC2), SEPT9 and Vimentin (VIM), achieved high diagnostic potential as biomarkers for diagnosing CRC in stool samples. Here, VIM is linked to colorectal carcinoma.